C
CRDF
Cardiff Oncology Inc
1.080
+0.020+1.89%After Hours: 1.099 +0.019 +1.77%19:32 10/09 EDT
OPEN/PREV CLOSE1.060/1.060
TODAY RANGE1.060-1.110
VOL298.12K
MARKET CAP84.02M
52 WEEK RANGE0.7566-3.310
AVG VOL (3M)1.04M
% TURNOVER0.35%
TURNOVER--
P/E (TTM)-1.8265
% RANGE4.72%
EPS(TTM)-0.5913
P/E(FORWARD)-1.8050
P/B2.789
BVPS0.3873
DIVIDEND--
P/S124.14
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP78.81M
SHARES OUTSTANDING77.80M
NEXT EARNINGS11/04-11/09
FREE FLOAT72.97M
LOT SIZE1
EX-DATE02/20/2019
News
Press Releases
Financial Reports
Profile
Dow Jones·09/15 10:38
Cardiff Oncology Raised to Buy From Neutral by HC Wainwright & Co.
Dow Jones·09/15 10:38
Cardiff Oncology Price Target Announced at $9.00/Share by HC Wainwright & Co.
Benzinga·09/15 10:28
HC Wainwright & Co. Upgrades Cardiff Oncology to Buy, Announces $9 Price Target
TipRanks·09/15 10:10
Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright
TipRanks·09/14 13:47
Cardiff Oncology Amends Onvansertib License, Resolves Litigation
TipRanks·09/14 13:00
Cardiff Oncology, Nerviano Medical Sciences reach settlement
TipRanks·08/17 11:06
Cardiff Oncology downgraded to Market Perform from Outperform at William Blair
TipRanks·08/15 09:01
Take-Two, Quantum, On, Cardiff, Autodesk Trending With Analysts
Dow Jones·08/12 19:13
Cardiff Oncology Cut to Market Perform From Outperform by William Blair
Benzinga·08/12 19:03
William Blair Downgrades Cardiff Oncology to Market Perform
TipRanks·08/12 11:06
Piper Sandler Remains a Buy on Cardiff Oncology (CRDF)
Same Industry
Name/Symbol
Change%
Price